Clinical Trials Update: July 26, 2007
Diabetic Neuropathy HIV Bronchitis
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
This study will evaluate the effectiveness of three different dose levels of an investigational drug to treat diabetic neuropathy. You may be eligible to participate if you are 18 or older, have type 1 or type 2 diabetes, have no history of drug or alcohol abuse, and are not pregnant or breastfeeding.
The research site is in Las Vegas, Nev.
This trial will evaluate the safety and effectiveness of a new integrase inhibitor to treat HIV. To qualify, you must be 18 or older, not pregnant or breastfeeding, and must have tested positive and begun treatment for HIV-1.
The research site is in Bronx, NY.
You may qualify for this study if you are a current or former smoker, your breathing has worsened over time, you have a "smokers cough," or you have been diagnosed with emphysema or chronic bronchitis. In addition, you must be 40 or older, have been a smoker for at least 20 years, have not had cancer in the past five years, and must be generally healthy or have controlled medical conditions. Participants will receive study related medical examinations, breathing tests, and investigational medication at no cost. Weekend appointments are available.
The research site is in Ann Arbor, Mich.
Copyright 2007 Thomson CenterWatch. All rights reserved.